Latest diabetic macular edema Stories
On-demand Launch Event Features the first U.S. Patient Injections of ILUVIEN ATLANTA, April 21, 2015 /PRNewswire/ -- Alimera Sciences, Inc.
Diabetic retinopathy in patients with DME is the fourth approved indication for EYLEA in the U.S. TARRYTOWN, N.Y., March 25, 2015 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
RnRMarketResearch.com adds “Diabetic Macular Edema – Pipeline Review, H1 2015” report to its store.
USC Eye Institute studies show that prescription drug Ranibizumab may help reduce cases of blindness by 75 percent. Los Angeles, CA (PRWEB) February 18, 2015
In patients with moderate or worse vision loss at baseline, those treated with EYLEA gained, on average, an additional full line or more on an eye chart when compared to those treated with alternative
Treatment of Visual Impairment due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO) and Diabetic Macular Edema (DME) are the Second and Third Indications for Eylea(®) in Canada
TARRYTOWN, N.Y., Nov. 18, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin, Ltd.
New research from Kantar Health’s National Health and Wellness Survey shows European patients with macular edema are more likely to use insulin and have been diagnosed longer. New
TARRYTOWN, N.Y., Oct. 17, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
Regeneron plans to submit sBLA for this indication by year end TARRYTOWN, N.Y., Sept. 16, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
- A serpent whose bite was fabled to produce intense thirst.